Health
SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net
A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…
As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
…
Continue Reading
-
General23 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News23 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General17 hours agoTribute unveiled for SA Police Brevet Sergeant Jason Doig after fatal 2023 shooting
-
Noosa News3 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred